GeneDx Holdings Corp. (WGS)
66.89
+0.28
(+0.42%)
USD |
NASDAQ |
Apr 07, 16:00
69.50
+2.61
(+3.90%)
After-Hours: 20:00
GeneDx Holdings Research and Development Expense (Quarterly) : 24.03M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Illumina, Inc. | 238.00M |
| Natera, Inc. | 175.19M |
| Guardant Health, Inc. | 98.26M |
| Delcath Systems, Inc. | 9.371M |
| CytoSorbents Corp. | 1.243M |